The Food and Drug Administration said it is investigating four reports of infants who were hospitalized after consuming the formula, including one who died.
The agency said one of the cases involved salmonella and three involved Cronobacter sakazakiim, a rare but dangerous germ that can cause blood infections and other serious complications.
The recall affects certain lots of Similac, Alimentum and EleCare with expiration dates of April 1, 2022, or later. The product was distributed throughout the U.S. and overseas, the company said in a statement. “We’re working diligently with our partners to investigate complaints related to these products, which we recognize include infant formula produced at this facility, while we work to resolve this safety concern as quickly as possible,” said FDA Deputy Commissioner Frank Yiannas.
Abbott could not specify how many units the recall includes, but brands like Similac are among the best-selling formulas in the U.S. and overseas.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
‘Bad Vegan,’ a Raw Food Success Story Gone Wrong, Is Your Next True Crime ObsessionThe film attempts to answer the burning question of so many of the world’s biggest scandals: how did someone with so much success mess up so badly?
Read more »
South Shore Restaurant Ditches Food Delivery Apps Made Popular During The Pandemic; 'I'm Not Making Money'“I think we’d be better off taking those dollars towards local advertisers that we have a better relationship with, as opposed to someone who's not invested in our community.'
Read more »
Flix Brewhouse in Round Rock uses 'Brewster' the robot as food runnerFlix Brewhouse in Round Rock bought a robot from Richtech, named Brewster, to help run food to customers in the theaters.
Read more »
New food festival coming to Tucson this MayThe Pueblos del Maíz Fiesta will start on May 5th and have events throughout the month across 4 cities.
Read more »
Reckitt baby food is problem child best kept homeOffloading the sluggish Enfamil unit would boost the Nurofen maker’s growth. But rivals Nestlé or Abbott would face regulatory hurdles, while a buyout group would probably pay less than the unit’s 5.4 bln pound book value. CEO Laxman Narasimhan is better off holding on.
Read more »